One connected operating journey

Build. License. Operate. Assure. Improve.

Navigate the full pharmaceutical manufacturing lifecycle—from the first facility decision to sustained GMP control and measurable improvement—without losing the connections between them.

How to use this pathway

Enter at the stage that matches the decision in front of you.

New projects can move from Build through Improve. Established manufacturers can enter at any point, follow the connected resources and trace the implications upstream and downstream. The stages organize the existing guides and tools; they do not replace the detailed requirements of a regulator or approved quality system.

01

Stage 01

Build

Turn a product and market strategy into a licensable facility.
What must exist—and work together—before the first commercial batch can be considered?

Define the product portfolio, capacity, technology, site, flows, utilities, equipment, organization and quality-system architecture before capital decisions become difficult to reverse.

Required outcomes
  • Approved business, product and capacity basis
  • GMP design and contamination-control strategy
  • Qualified facility, utilities, equipment and people
  • Evidence-based readiness gates for start-up

Core hub

Start a Pharmaceutical Manufacturing Facility

Follow the end-to-end roadmap from concept and feasibility to inspection and controlled commercial start-up.

Open resource

Planning guide

Facility, Utilities and Equipment Planning

Translate product and process needs into layouts, flows, clean utilities, equipment and lifecycle evidence.

Open resource

Interactive workbook

Factory Setup and GMP Readiness

Assess 112 controls across 14 workstreams and ten project decision gates.

Open resource
02

Stage 02

License

Connect the legal entity, site, GMP status, product and supply chain.
Which authorizations must align before manufacture, import, export or sale is lawful?

Treat licensing as a controlled stack rather than a single certificate. Map central, State, national and regional pathways, dossier ownership, local representation and lifecycle duties.

Required outcomes
  • Country and authority map
  • Facility, manufacturing and GMP authorization pathway
  • Product-registration and dossier strategy
  • Import, distribution and post-market responsibilities

Regulatory framework

Africa–India Licensing and Regulatory Framework

Compare operating models and connect eight authorization layers from investment to post-market control.

Open resource

Documentation system

QMS Documentation Master Index

Plan the document families, ownership and evidence expected across the pharmaceutical quality system.

Open resource

Readiness control

Regulatory and Inspection Gates

Use the factory-readiness workbook to connect permissions, licences, qualification and inspection evidence.

Open resource
03

Stage 03

Operate

Convert approved systems into reliable work on every shift.
Can trained people consistently execute the process and reconstruct what happened?

Run production, laboratories, warehouses and support functions through usable procedures, competent people, controlled records, maintained equipment and disciplined daily decisions.

Required outcomes
  • Repeatable GMP routines and clear accountability
  • Competent people—not attendance records alone
  • Contemporaneous, traceable production and laboratory data
  • Controlled materials, equipment, processes and records

Core hub

Operate a Pharmaceutical Manufacturing Facility

Connect planning, materials, production, laboratories, engineering, release, supply and management review in one operating system.

Open resource

People system

GMP Training Effectiveness

Move from training completion to demonstrated knowledge, competence and sustained performance.

Open resource
04

Stage 04

Assure

Verify that the process, data and extended system remain in control.
What objective evidence shows that products, processes and decisions remain trustworthy?

Use independent oversight, validation, monitoring, self-inspection, investigations and supplier controls to detect risk early and protect the validated state.

Required outcomes
  • Connected pharmaceutical quality-system oversight
  • Science- and risk-based validation and monitoring
  • Defensible deviation and OOS conclusions
  • Reliable suppliers, audit trails and internal inspections

System guide

Pharmaceutical Quality System

See how risk, knowledge, monitoring, investigations, change and management review work as one loop.

Open resource
05

Stage 05

Improve

Turn signals, failures and experience into stronger capability.
Did the action reduce the intended risk—and what should the wider system learn?

Close the loop through effective CAPA, controlled change, trend review, management decisions and knowledge transfer. Improvement means a demonstrably stronger system, not merely closed records.

Required outcomes
  • Cause-linked corrective and preventive actions
  • Predefined effectiveness criteria and review periods
  • Controlled implementation without loss of validated state
  • Trends and lessons converted into management action

Outcome guide

CAPA Effectiveness Checks

Define what success looks like before evidence arrives, then make a documented closure decision.

Open resource

Lifecycle guide

Change Control in Pharmaceutical Manufacturing

Connect proposal, risk, validation, implementation and post-implementation review.

Open resource

Working resources

Quality Systems Toolkit

Use printable investigation, CAPA, data, supplier and validation workbooks to structure evidence.

Open resource

Browse without a stage

Use the full resource libraries.

Search all practical guides by quality-system area, or go directly to the interactive and printable tools.

Browse all guides Browse all tools